63 related articles for article (PubMed ID: 6140228)
1. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II.
Saletu B; Grünberger J; Linzmayer L; Dubini A
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):544-51. PubMed ID: 6140228
[No Abstract] [Full Text] [Related]
2. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
Saletu B; Grünberger J; Linzmayer L; Dubini A
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
Galliani G; Restelli A; Rosina R; Glässer A
Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
[TBL] [Abstract][Full Text] [Related]
4. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
[TBL] [Abstract][Full Text] [Related]
5. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
6. [Electroencephalographic profile of the neuroleptic, zetidoline].
Zapletálek M; Libiger J; Hanus H; Valach M
Cesk Psychiatr; 1984 Jun; 80(3):139-42. PubMed ID: 6148150
[No Abstract] [Full Text] [Related]
7. Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.
Barbieri C; Parodi M; Bruno S; Bertassi F; Benaglia D; Moser P; Meroni R; Dubini A
Eur J Clin Pharmacol; 1984; 26(1):29-32. PubMed ID: 6143669
[TBL] [Abstract][Full Text] [Related]
8. Pharmaco-EEG studies with fluperlapine.
Matejcek M; Neff G; Tjeerdsma H; Krebs E
Arzneimittelforschung; 1984; 34(1A):114-20. PubMed ID: 6145426
[TBL] [Abstract][Full Text] [Related]
9. EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug.
Fink M; Irwin P
Psychopharmacology (Berl); 1980; 72(1):67-71. PubMed ID: 6110218
[TBL] [Abstract][Full Text] [Related]
10. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
[TBL] [Abstract][Full Text] [Related]
11. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
12. [Intercentral interactions during typical and atypical neuroleptics administration].
Kachalova LM; Popova NS
Biull Eksp Biol Med; 1999 May; 127(5):512-5. PubMed ID: 10399568
[No Abstract] [Full Text] [Related]
13. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
14. Pharmaco-EEG profiles of typical and atypical antidepressants.
Saletu B
Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895
[TBL] [Abstract][Full Text] [Related]
15. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
16. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.
Desai M; Tanus-Santos JE; Li L; Gorski JC; Arefayene M; Liu Y; Desta Z; Flockhart DA
Pharmacogenomics J; 2003; 3(2):105-13. PubMed ID: 12746736
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
19. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
20. A comparison of some psychological and physiological effects exerted by zetidoline (DL308) and by oxazepam.
Herbert M; Standen PJ; Short AH; Birmingham AT
Psychopharmacology (Berl); 1983; 81(4):335-9. PubMed ID: 6140700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
